相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice
Vasiliki Katsi et al.
CURRENT HYPERTENSION REVIEWS (2022)
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
Yongjun Sui et al.
JCI INSIGHT (2021)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2
Mahmoud Gheblawi et al.
CIRCULATION RESEARCH (2020)
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19
Hin Chu et al.
CLINICAL INFECTIOUS DISEASES (2020)
ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway
Rensong Ye et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Controversial Relationship Between Renin-Angiotensin System Inhibitors and Severity of COVID-19 Announcing a Large Multicentre Case-Control Study in Italy
Augusto Di Castelnuovo et al.
HYPERTENSION (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
Hao Cheng et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
Vincent J. Munster et al.
NATURE (2020)
Antiviral activities of type I interferons to SARS-CoV-2 infection
Emily Mantlo et al.
ANTIVIRAL RESEARCH (2020)
ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
Bruna G. G. Pinto et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post- Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques
Thomas Musich et al.
JOURNAL OF VIROLOGY (2020)
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Kumari G. Lokugamage et al.
JOURNAL OF VIROLOGY (2020)
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
Nehla Banu et al.
LIFE SCIENCES (2020)
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
Olusegun O. Onabajo et al.
NATURE GENETICS (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
Zofia Wicik et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response
Yongjun Sui et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Decoding type I and III interferon signalling during viral infection
Emily Mesev et al.
NATURE MICROBIOLOGY (2019)
PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infection
Rachel E. Rigby et al.
SCIENTIFIC REPORTS (2019)
The interferon paradox: can inhibiting an antiviral mechanism advance an HIV cure?
Steven G. Deeks et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection
Yanpeng Li et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2017)
The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination
Yong Hu et al.
JOURNAL OF VIROLOGY (2017)
Understanding Interferon Subtype Therapy for Viral Infections: Harnessing the Power of the Innate Immune System.
Cassandra M. Berry
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes
Luna A. Zaritsky et al.
JOURNAL OF VIROLOGY (2015)
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets
Fan Jiang et al.
NATURE REVIEWS CARDIOLOGY (2014)
Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses
Vineet D. Menachery et al.
MBIO (2014)
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
Zhen Zou et al.
NATURE COMMUNICATIONS (2014)
Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
Penghui Yang et al.
SCIENTIFIC REPORTS (2014)
ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
A. C. Simoes e Silva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Primary Severe Acute Respiratory Syndrome Coronavirus Infection Limits Replication but Not Lung Inflammation upon Homologous Rechallenge
Candice Clay et al.
JOURNAL OF VIROLOGY (2012)
IFITM3 restricts the morbidity and mortality associated with influenza
Aaron R. Everitt et al.
NATURE (2012)
Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
Roelie M. Woesten-van Asperen et al.
JOURNAL OF PATHOLOGY (2011)
Mammalian microRNAs predominantly act to decrease target mRNA levels
Huili Guo et al.
NATURE (2010)
Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques
Yongjun Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro
Susan F. Dosch et al.
VIRUS RESEARCH (2009)
The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice
Yumiko Imai et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Intracellular cytokine optimization and standard operating procedure
Laurie Lamoreaux et al.
NATURE PROTOCOLS (2006)
Angiotensin-converting enzyme 2 in lung diseases
Keiji Kuba et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Simian human immunodeficiency virus-associated pneumonia correlates with increased expression of MCP_1, CXCL10, and viral RNA in the lungs of rhesus Macaques
YJ Sui et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3
M Spiegel et al.
JOURNAL OF VIROLOGY (2005)
IFN-α subtypes differentially affect human T cell motility
GR Foster et al.
JOURNAL OF IMMUNOLOGY (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
S Dupuis et al.
NATURE GENETICS (2003)
分享论文
